The service positions itself as a low-cost alternative to conventional care, charging roughly $5 monthly for platform access and about $50 for medication. This price point significantly undercuts standard dermatology visits, which typically range between $150 and $300. While the software automates the diagnostic workflow, human oversight remains partially integrated into the rollout. Physicians are required to review the initial 100 prescriptions manually, followed by a retrospective check of the next 400 cases. Moving forward, the company must ensure that doctors audit at least 10% of all monthly prescriptions.
Despite the operational efficiency, the shift has sparked debate regarding the boundaries of digital medicine. John Whyte, CEO of the American Medical Association, cautioned that AI tools should not attempt to practice medicine autonomously, raising concerns about the risks of delegating clinical judgment to algorithms.
Comments (0)
No comments yet. Be the first!